News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Subsidiary Gets Class I Recall for Implantable Infusion Pumps



7/26/2013 8:48:05 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Codman & Shurtleff, a division of Johnson & Johnson subsidiary DePuy Synthes, gets the FDA's highest warning level for issues with certain lots of its programmable infusion pumps. The FDA puts its highest-risk label on a recall of programmable infusion pumps made by Codman &Shurtleff Inc., a division of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics. Codman's implanted MedStream pumps were recalled over a potential defect in a component that measures the contents of the pump reservoir.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES